Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:: A Population-Based Retrospective Cohort Study.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
13 04 2021
Historique:
pubmed: 6 4 2021
medline: 24 12 2021
entrez: 5 4 2021
Statut: ppublish

Résumé

Bariatric surgery has been shown to significantly reduce cardiovascular risk factors. However, whether surgery can reduce major adverse cardiovascular events (MACE), especially in patients with established cardiovascular disease, remains poorly understood. The present study aims to determine the association between bariatric surgery and MACE among patients with cardiovascular disease and severe obesity. This was a propensity score-matched cohort study using province-wide multiple-linked administrative databases in Ontario, Canada. Patients with previous ischemic heart disease or heart failure who received bariatric surgery were matched on age, sex, heart failure history, and a propensity score to similar controls from a primary care medical record database in a 1:1 ratio. The primary outcome was the incidence of extended MACE (first occurrence of all-cause mortality, myocardial infarction, coronary revascularization, cerebrovascular events, and heart failure hospitalization). Secondary outcome included 3-component MACE (myocardial infarction, ischemic stroke, and all-cause mortality). Outcomes were evaluated through a combination of matching via propensity score and subsequent multivariable adjustment. A total of 2638 patients (n=1319 in each group) were included, with a median follow-up time of 4.6 years. The primary outcome occurred in 11.5% (151/1319) of the surgery group and 19.6% (259/1319) of the controls (adjusted hazard ratio [HR], 0.58 [95% CI, 0.48-0.71]; Bariatric surgery was associated with a lower incidence of MACE in patients with cardiovascular disease and obesity. These findings require confirmation by a large-scale randomized trial.

Sections du résumé

BACKGROUND
Bariatric surgery has been shown to significantly reduce cardiovascular risk factors. However, whether surgery can reduce major adverse cardiovascular events (MACE), especially in patients with established cardiovascular disease, remains poorly understood. The present study aims to determine the association between bariatric surgery and MACE among patients with cardiovascular disease and severe obesity.
METHODS
This was a propensity score-matched cohort study using province-wide multiple-linked administrative databases in Ontario, Canada. Patients with previous ischemic heart disease or heart failure who received bariatric surgery were matched on age, sex, heart failure history, and a propensity score to similar controls from a primary care medical record database in a 1:1 ratio. The primary outcome was the incidence of extended MACE (first occurrence of all-cause mortality, myocardial infarction, coronary revascularization, cerebrovascular events, and heart failure hospitalization). Secondary outcome included 3-component MACE (myocardial infarction, ischemic stroke, and all-cause mortality). Outcomes were evaluated through a combination of matching via propensity score and subsequent multivariable adjustment.
RESULTS
A total of 2638 patients (n=1319 in each group) were included, with a median follow-up time of 4.6 years. The primary outcome occurred in 11.5% (151/1319) of the surgery group and 19.6% (259/1319) of the controls (adjusted hazard ratio [HR], 0.58 [95% CI, 0.48-0.71];
CONCLUSIONS
Bariatric surgery was associated with a lower incidence of MACE in patients with cardiovascular disease and obesity. These findings require confirmation by a large-scale randomized trial.

Identifiants

pubmed: 33813836
doi: 10.1161/CIRCULATIONAHA.120.052386
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1468-1480

Commentaires et corrections

Type : CommentIn

Auteurs

Aristithes G Doumouras (AG)

Division of General Surgery (A.G.D., Y.L., D.H., M.A.), McMaster University, Hamilton, Ontario, Canada.
ICES, Toronto, Ontario, Canada (A.G.D., J.M.P., B.S., D.H., M.A.).

Jorge A Wong (JA)

Department of Medicine (J.A.W., S.Y.), McMaster University, Hamilton, Ontario, Canada.
Population Health Research Institute, Hamilton Health Sciences and McMaster University, Ontario, Canada (J.A.W., L.T., S.Y.).

J Michael Paterson (JM)

Department of Family Medicine (J.M.P.), McMaster University, Hamilton, Ontario, Canada.
ICES, Toronto, Ontario, Canada (A.G.D., J.M.P., B.S., D.H., M.A.).
Institute of Health Policy, Management, and Evaluation, University of Toronto, Ontario, Canada. (J.M.P.).

Yung Lee (Y)

Division of General Surgery (A.G.D., Y.L., D.H., M.A.), McMaster University, Hamilton, Ontario, Canada.

Branavan Sivapathasundaram (B)

ICES, Toronto, Ontario, Canada (A.G.D., J.M.P., B.S., D.H., M.A.).

Jean-Eric Tarride (JE)

Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences (J.-E.T., L.T.), McMaster University, Hamilton, Ontario, Canada.
Center for Health Economics and Policy Analysis (J.-E.T.), McMaster University, Hamilton, Ontario, Canada.
Programs for Assessment of Technology in Health, The Research Institute of St Joe's Hamilton, St Joseph's Healthcare Hamilton, Ontario, Canada (J.-E.T.).

Lehana Thabane (L)

Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences (J.-E.T., L.T.), McMaster University, Hamilton, Ontario, Canada.
Population Health Research Institute, Hamilton Health Sciences and McMaster University, Ontario, Canada (J.A.W., L.T., S.Y.).

Dennis Hong (D)

Division of General Surgery (A.G.D., Y.L., D.H., M.A.), McMaster University, Hamilton, Ontario, Canada.
ICES, Toronto, Ontario, Canada (A.G.D., J.M.P., B.S., D.H., M.A.).

Salim Yusuf (S)

Department of Medicine (J.A.W., S.Y.), McMaster University, Hamilton, Ontario, Canada.
Population Health Research Institute, Hamilton Health Sciences and McMaster University, Ontario, Canada (J.A.W., L.T., S.Y.).

Mehran Anvari (M)

Division of General Surgery (A.G.D., Y.L., D.H., M.A.), McMaster University, Hamilton, Ontario, Canada.
ICES, Toronto, Ontario, Canada (A.G.D., J.M.P., B.S., D.H., M.A.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH